Cargando…
Serum biomarker panels for the diagnosis of gastric cancer
Gastric cancer is a leading cause of mortality due to neoplastic disease. Although early detection of gastric cancers can decrease the mortality rate, it remains a diagnostic challenge because of the lack of effective biomarkers. In this study, fifteen gastric cancer patients and ten healthy subject...
Autores principales: | Wu, Dan, Zhang, Pinglu, Ma, Ji, Xu, Jinbo, Yang, Li, Xu, Weidan, Que, Haifeng, Chen, Meifen, Xu, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488129/ https://www.ncbi.nlm.nih.gov/pubmed/30873760 http://dx.doi.org/10.1002/cam4.2055 |
Ejemplares similares
-
Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012) -
Serum biomarker panels for diagnosis of gastric cancer
por: Tong, Weihua, et al.
Publicado: (2016) -
Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021) -
Identification of a six‐miRNA panel in serum benefiting pancreatic cancer diagnosis
por: Zou, Xuan, et al.
Publicado: (2019) -
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)